Marien Tracy, Sankin Alex, Lepor Herbert
Department of Urology, New York University School of Medicine, New York, New York, USA.
J Urol. 2009 Apr;181(4):1817-22. doi: 10.1016/j.juro.2008.11.105. Epub 2009 Feb 23.
The development of erectile dysfunction represents a major concern for potent men with localized prostate cancer undergoing open radical retropubic prostatectomy. We identified factors predicting the preservation of erectile function in men undergoing open radical retropubic prostatectomy.
Between October 2000 and September 2005 a total of 1,110 men underwent open radical retropubic prostatectomy by a single surgeon. The UCLA-PCI was self-administered at baseline, and at 3, 6, 12 and 24 months postoperatively. The 728 (66%) men who responded that they engaged in sexual intercourse with or without taking phosphodiesterase type 5 inhibitors in the month before surgery and who were not dependent on intracavernous injections, intraurethral suppositories, vacuum devices or penile prostheses were considered potent. Followup was available for 659 men. Of the evaluable men 25 received salvage radiation therapy, adjuvant chemotherapy or hormonal therapy and were excluded from the study. Univariate and multivariate analyses using a logistic regression model were used to identify factors predicting the preservation of potency.
Age, coronary artery disease, diabetes mellitus, quality of preoperative erections, frequency of intercourse, hypertension, neurovascular bundle preservation and the use of phosphodiesterase type 5 inhibitors preoperatively predicted the preservation of potency. On multivariate analysis age, no history of diabetes mellitus and nerve sparing were independent predictors of the preservation of potency.
We identified many factors that were predictors of the preservation of potency after open radical retropubic prostatectomy. Only age, no history of diabetes mellitus and neurovascular bundle preservation were independent predictors. These parameters should be considered when counseling surgical candidates so that erectile function expectations are realistic.
勃起功能障碍的发生是接受开放性耻骨后根治性前列腺切除术的局限性前列腺癌男性患者的一个主要担忧。我们确定了预测接受开放性耻骨后根治性前列腺切除术男性勃起功能保留情况的因素。
2000年10月至2005年9月期间,共有1110名男性由一名外科医生进行了开放性耻骨后根治性前列腺切除术。术前、术后3、6、12和24个月由患者自行填写加州大学洛杉矶分校前列腺癌指数(UCLA-PCI)。在术前一个月有性行为(无论是否服用5型磷酸二酯酶抑制剂)且不依赖海绵体内注射、尿道内栓剂、真空装置或阴茎假体的728名(66%)男性被视为性功能正常。659名男性有随访资料。在可评估的男性中,25名接受了挽救性放疗、辅助化疗或激素治疗,被排除在研究之外。使用逻辑回归模型进行单因素和多因素分析,以确定预测性功能保留的因素。
年龄、冠状动脉疾病、糖尿病、术前勃起质量、性交频率、高血压、神经血管束保留情况以及术前使用5型磷酸二酯酶抑制剂可预测性功能的保留。多因素分析显示,年龄、无糖尿病史和保留神经是性功能保留的独立预测因素。
我们确定了许多预测开放性耻骨后根治性前列腺切除术后性功能保留情况的因素。只有年龄、无糖尿病史和神经血管束保留是独立的预测因素。在为手术候选人提供咨询时应考虑这些参数,以便对勃起功能的预期符合实际情况。